Artemis Global Life Sciences Limited reported audited consolidated and standalone and earnings results for the year ended March 31, 2018. For the year, on consolidated basis, the company reported revenue from operations of INR 5,027.871 million against INR 4,633.049 million a year ago. Total revenue was INR 5,070.860 million against INR 4,696.193 million a year ago. Profit before tax was INR 349.043 million against INR 325.599 million a year ago. Profit for the period was INR 262.763 million or INR 3.97 per basic and diluted share against INR 271.149 million or INR 4.10 per basic and diluted share a year ago. Net cash from operating activities was INR 824.997 million against INR 522.882 million a year ago. Purchase of fixed assets/CWIP was INR 613.389 million against INR 718.453 million a year ago. For the year, on standalone basis, the company reported revenue from operations of INR 4.080 million against INR 4.080 million a year ago. Loss before tax was INR 3.781 million against profit before tax of INR 2.112 million a year ago. Loss for the period was INR 2.988 million or INR 0.05 per basic and diluted share against profit for the period of INR 1.481 million or INR 0.02 per basic and diluted share a year ago. Net cash used in operating activities was INR 4.286 million against net cash from operating activities of INR 37.369 million a year ago.